Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202699010 | Acetaminophen + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215588019 | Acetaminophen + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478744012 | Acetaminophen+phenyltoloxamine citrate+salicylamide 300mg/20mg/200mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2820832014 | Paracetamol + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3469707018 | Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3469708011 | Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3469709015 | Product containing acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3469710013 | Product containing paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3490467019 | Product containing paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569299017 | Product containing only paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569300013 | Product containing only acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569301012 | Product containing only paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3681519012 | Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3681520018 | Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3681521019 | Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3681522014 | Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 105046901000001117 | Paracetamol + phenyltoloxamine citrate + salicylamide 300mg/20mg/200mg capsule | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Is a | Product containing phenyltoloxamine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Is a | Acetaminophen compound preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Ethanolamine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Sedating antihistamine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Non-opioid analgesic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Phenyltoloxamine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Is a | Product containing paracetamol and phenyltoloxamine citrate and salicylamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Salicylamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Cardiovascular agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has basis of strength substance | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 300 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has basis of strength substance | Phenyltoloxamine citrate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has active ingredient | Salicylamide | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has basis of strength substance | Salicylamide | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has precise active ingredient | Salicylamide | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has precise active ingredient | Phenyltoloxamine citrate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has precise active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Is a | Product containing paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Is a | Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has basis of strength substance | Salicylamide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has basis of strength substance | Phenyltoloxamine citrate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has precise active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has precise active ingredient | Salicylamide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has basis of strength substance | Paracetamol | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule | Has precise active ingredient | Phenyltoloxamine citrate | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR